Table 2 Positivity of CPE development and protein blotting of treatment groups in Experiment C and D.
From: Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus
Test | Virus assay (CPE) | Protein blotting | ||||||
|---|---|---|---|---|---|---|---|---|
Experiment/Organ | C (Day 13–14 p.i.) | D (Day 21 p.i.) | C (Day 13–14 p.i.) | D (Day 21 p.i.) | ||||
| Â | Group | Group | ||||||
| Â | v | pv | v | pv | v | pv | v | pv |
Uterus | 5/5 | 5/5 | 5/5 | 5/5 | 5/5 | 5/5 | 5/5 | 5/5 |
Neonate | 11/18 | 16/18 | - | - | 12/18 | 15/18 | - | - |
Placenta | - | - | 16/20 | 10/10 | - | - | 14/20 | 8/10 |
Fetus | - | - | 14/20 | 7/10 | - | - | 12/20 | 6/10 |
Embryo* | - | - | - | 8/8 | - | - | - | 8/8 |